✦ LIBER ✦

Outcomes of autologous stem cell transplantation in patients with multiple myeloma who received dexamethasone-based nonmyelosuppressive induction therapy

✍ Scribed by Anagnostopoulos, A; Aleman, A; Yang, Y; Donato, M; Weber, D; Champlin, R; Smith, T; Alexanian, R; Giralt, S

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Safety of therapeutic anticoagulation in

✍ Schimmer, A D; Stewart, A K; Keating, A; MacKinnon, J; Crump, M; Sutton, D M; Sh 📂 Article 📅 1998 🏛 Nature Publishing Group 🌐 English ⚖ 34 KB

Outcome after autologous stem cell trans

✍ Shaji K. Kumar; David Dingli; Martha Q. Lacy; Angela Dispenzieri; Suzanne R. Hay 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 150 KB

First-line thalidomide–dexamethasone the

✍ Abdelkefi, A; Torjman, L; Ben Romdhane, N; Ladeb, S; El Omri, H; Ben Othman, T; 📂 Article 📅 2005 🏛 Nature Publishing Group 🌐 English ⚖ 139 KB

Initial Therapy of Multiple Myeloma in P

✍ William Bensinger 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 176 KB

Thalidomide, dexamethasone and lovastati

✍ Marek Hus; Norbert Grzasko; Marta Szostek; Andrzej Pluta; Grzegorz Helbig; Dariu 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 218 KB

High-dose therapy/autologous stem cell t

✍ Nadal, E; Giné, E; Bladé, J; Esteve, J; Rosiñol, L; Fernández-Avilés, F; Marin, 📂 Article 📅 2004 🏛 Nature Publishing Group 🌐 English ⚖ 127 KB